The level of minimal residual disease in the bone marrow of patients with multiple myeloma before high-dose therapy and autologous blood stem cell transplantation is an independent predictive parameter.
暂无分享,去创建一个
I. Bruns | G. Kobbe | R. Fenk | R. Haas | R. Kronenwett | Mark Korthals | F. Zohren | N. Sehnke | Jochen Mau